Search Results - "Casalino, Simona"

Refine Results
  1. 1

    Targeting KRAS: The Elephant in the Room of Epithelial Cancers by Merz, Valeria, Gaule, Marina, Zecchetto, Camilla, Cavaliere, Alessandro, Casalino, Simona, Pesoni, Camilla, Contarelli, Serena, Sabbadini, Fabio, Bertolini, Monica, Mangiameli, Domenico, Milella, Michele, Fedele, Vita, Melisi, Davide

    Published in Frontiers in oncology (11-03-2021)
    “…Mutations of the proto-oncogene KRAS are the most frequent gain-of-function alterations found in cancer. KRAS is mutated in about 30% of all human tumors, but…”
    Get full text
    Journal Article
  2. 2

    Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear by Melisi, Davide, Casalino, Simona, Pietrobono, Silvia, Quinzii, Alberto, Zecchetto, Camilla, Merz, Valeria

    Published in Therapeutic advances in medical oncology (01-01-2024)
    “…The approval of novel therapeutic agents remains widely reliant on evidence derived from large phase III randomized controlled trials. Liposomal irinotecan…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer by Cavaliere, Alessandro, Merz, Valeria, Casalino, Simona, Zecchetto, Camilla, Simionato, Francesca, Salt, Hayley Louise, Contarelli, Serena, Santoro, Raffaela, Melisi, Davide

    Published in Journal of gastric cancer (01-12-2019)
    “…Preoperative chemo- and radiotherapeutic strategies followed by surgery are currently a standard approach for treating locally advanced gastric and…”
    Get full text
    Journal Article
  8. 8

    Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer by Merz, Valeria, Mangiameli, Domenico, Zecchetto, Camilla, Quinzii, Alberto, Pietrobono, Silvia, Messina, Carlo, Casalino, Simona, Gaule, Marina, Pesoni, Camilla, Vitale, Pasquale, Trentin, Chiara, Frisinghelli, Michela, Caffo, Orazio, Melisi, Davide

    Published in Frontiers in surgery (04-05-2022)
    “…The mainstay treatment for patients with immediate resectable pancreatic cancer remains upfront surgery, which represents the only potentially curative…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer by Cavaliere, Alessandro, Merz, Valeria, Casalino, Simona, Zecchetto, Camilla, Simionato, Francesca, Salt, Hayley Louise, Contarelli, Serena, Santoro, Raffaela, Melisi, Davide

    Published in Journal of gastric cancer (2019)
    “…Preoperative chemo- and radiotherapeutic strategies followed by surgery are currently a standard approach for treating locally advanced gastric and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports by Quinzii, Alberto, Zecchetto, Camilla, Casalino, Simona, Gaule, Marina, Pesoni, Camilla, Merz, Valeria, Contarelli, Serena, Pietrobono, Silvia, Benhadji, Karim A., Melisi, Davide

    Published in Clinical drug investigation (01-08-2022)
    “…Genomic alterations responsible for a ligand-independent activation of these tyrosine kinases receptors, including activating point mutations, amplifications,…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients by Merz, Valeria, Cavaliere, Alessandro, Messina, Carlo, Salati, Massimiliano, Zecchetto, Camilla, Casalino, Simona, Milella, Michele, Caffo, Orazio, Melisi, Davide

    Published in Cancers (30-04-2020)
    “…Pancreatic cancer is one of the most lethal solid tumors. In many European countries gemcitabine plus nab-paclitaxel is the preferred first-line treatment. An…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20